Viberzi Increases Risk of Pancreatitis

F. A. KelleyDefective Drugs


Viberzi, a medication prescribed for irritable bowel syndrome, may increase the risk of pancreatitis—severe inflammation of the pancreas. Two people died after taking Viberzi and the U.S. Food and Drug Administration (FDA) has issued a safety communication warning patients of … Read More

Actemra Associated With Hundreds of Deaths

Martin AbernathyDefective Drugs


RA Drug, Actemra, Focus of Investigation Actemra (tocilizumab), which is manufactured by drug maker, Roche/Genentech, and which was approved to treat adults who have been diagnosed with moderate to severe active rheumatoid arthritis (RA), has been tied to serious adverse … Read More